Pancreatic Cancer Research

ResearcherNortheastern UniversityNo recent work listed

Jing Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5371-1899; OpenAlex author ID A5101661627. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Diagnostic value of neuronal pentraxin II methylation in patients with pancreatic cancer: Meta-analysis. Co-author DOI 10.1111/ijcp.14443↗
  2. Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. Co-author DOI 10.1186/1471-2407-14-75↗
  3. Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles. Co-author DOI 10.3791/3612↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuqiang Nie · 1 shared paper, 2021 · strength 0.15
  2. Wenqi Huang · 1 shared paper, 2021 · strength 0.15
  3. Mansoor M. Amiji · 2 shared papers, 2012–2014 · strength 0.14
  4. Amit Singh · 1 shared paper, 2014 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.